New analysis confirms canagliflozin's cardiovascular and kidney benefits in older adults

Although the overall incidence of adverse events increased with age, the effects of canagliflozin on safety outcomes including acute kidney injury, volume depletion, urinary tract infections and hypoglycemia, were not modified by age.

Study: "Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A pooled secondary analysis of the CANVAS Program and CREDENCE trial"

Source:

American Society of Nephrology